Iterum Therapeutics plc
ITRM
$0.99
-$0.007-0.70%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.89M | -6.58M | -6.09M | -5.00M | -7.10M |
| Total Depreciation and Amortization | 349.00K | 261.00K | 8.00K | 8.00K | 7.00K |
| Total Amortization of Deferred Charges | 194.00K | -1.40M | 2.55M | 569.00K | 569.00K |
| Total Other Non-Cash Items | 1.55M | 4.89M | 935.00K | 1.14M | 1.20M |
| Change in Net Operating Assets | -266.00K | -1.42M | -73.00K | -3.48M | -7.76M |
| Cash from Operations | -3.06M | -4.26M | -2.67M | -6.76M | -13.08M |
| Capital Expenditure | -2.00K | 0.00 | 0.00 | -2.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 1.10M | 5.70M | 4.20M | 7.21M |
| Cash from Investing | -2.00K | 1.10M | 5.70M | 4.20M | 7.21M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -14.75M | -- | -- | -- | -- |
| Issuance of Common Stock | 6.36M | 13.88M | 5.43M | 167.00K | 7.22M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -8.39M | 13.88M | 5.43M | 167.00K | 7.22M |
| Foreign Exchange rate Adjustments | -23.00K | -2.00K | -28.00K | -18.00K | -27.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.47M | 10.72M | 8.43M | -2.41M | 1.32M |